Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Sight Sciences, Inc. incurred term loan of up to $65.0 million with Hercules Capital, Inc at greater of (i) 10.35% or (ii) the Wall Street Journal prime rate plus 2.35% maturing July 1, 2028.
- Instrument
- term loan
- Principal
- up to $65.0 million
- Counterparty
- Hercules Capital, Inc
- Rate
- greater of (i) 10.35% or (ii) the Wall Street Journal prime rate plus 2.35%
- Maturity
- July 1, 2028
- Event
- incurrence
Exact text from the filing
Sight Sciences, Inc. (“Company” and collectively with any Company affiliates that are made party to the Loan Agreement, “Borrower”) entered into a Loan and Security Agreement (the “Loan Agreement”) with Hercules Capital, Inc (“Hercules” or “Agent”) and certain affiliates of Hercules (collectively with Hercules, the “Lender”), which provides for a senior secured term loan facility in the aggregate principal amount of up to $65.0 million (the “Term Loan Facility”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Sight Sciences, Inc. entered into Loan and Security Agreement with Hercules Capital, Inc. and certain affiliates valued at $65.0 million (effective 2024-01-22).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- Hercules Capital, Inc. and certain affiliates
- Value
- $65.0 million
- Effective
- 2024-01-22
Exact text from the filing
On January 22, 2024 (the “Closing Date”), Sight Sciences, Inc. (“Company” and collectively with any Company affiliates that are made party to the Loan Agreement, “Borrower”) entered into a Loan and Security Agreement (the “Loan Agreement”) with Hercules Capital, Inc (“Hercules” or “Agent”) and certain affiliates of Hercules (collectively with Hercules, the “Lender”), which provides for a senior secured term loan facility in the aggregate principal amount of up to $65.0 million (the “Term Loan Facility”).
View on SEC.gov